Jules L. Dienstag
- Hepatology top 0.01%
- Hepatitis C virus research 125
- Hepatitis Viruses Studies and Epidemiology 62
- Liver Disease and Transplantation 31
- Liver Diseases and Immunity 18
- Epidemiology top 0.01%
- Hepatitis B Virus Studies 150
- Liver Disease Diagnosis and Treatment 102
- Infectious Diseases top 0.2%
- Viral gastroenteritis research and epidemiology 23
- Virology top 1%
- Transplantation top 2%
-
- Innovations in Medical Education 12
- Co-authors
- Eugene R. SchiffJay H. HoofnagleGirish N. VyasKaren L. LindsayWilliam M. LeeJohn G. McHutchisonHerbert L. BonkovskyAnna S. Lok
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Jules L. Dienstag
266 papers receiving 25.5k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Hepatology 21.6k
- Epidemiology 21.0k
- Infectious Diseases 3.6k
- Virology 497
- Transplantation 239
Countries citing papers authored by Jules L. Dienstag
This map shows the geographic impact of Jules L. Dienstag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jules L. Dienstag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jules L. Dienstag more than expected).
Fields of papers citing papers by Jules L. Dienstag
This network shows the impact of papers produced by Jules L. Dienstag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jules L. Dienstag. The network helps show where Jules L. Dienstag may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jules L. Dienstag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | 2020 | 69 | |
| 3 | 2009 | 30 | |
| 4 | 2008 | 452 | |
| 5 | 2008 | 22 | |
| 6 | 2008 | 17 | |
| 7 | 2007 | 98 | |
| 8 | 2003 | 95 | |
| 9 | 2003 | 181 | |
| 10 | Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients. | 1998 | 13 |
| 11 | A Placebo Controlled Study of Lamivudine and Interferonalpha-2b in Patients with Chronic Hepatitis B Who PreviouslyFailed Interferon Therapy | 1998 | 30 |
| 12 | 1994 | 71 | |
| 13 | 1991 | 31 | |
| 14 | 1990 | 25 | |
| 15 | Transfusion-associated non-A, non-B hepatitis. Where do we go from here? | 1988 | 9 |
| 16 | 1988 | 8 | |
| 17 | 1985 | 1 | |
| 18 | 1977 | 13 | |
| 19 | 1977 | 1 | |
| 20 | Non-A, non-B hepatitis. | 1976 | 126 |
About Jules L. Dienstag
Jules L. Dienstag is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 268 papers that have together received 27.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (150 papers), Hepatitis C virus research (125 papers), Liver Disease Diagnosis and Treatment (102 papers), Hepatitis Viruses Studies and Epidemiology (62 papers), Liver Disease and Transplantation (31 papers), Viral gastroenteritis research and epidemiology (23 papers), Liver Diseases and Immunity (18 papers) and Innovations in Medical Education (12 papers). The work is most often cited by research in Hepatology (21.6k citations), Epidemiology (21.0k citations) and Infectious Diseases (3.6k citations). Jules L. Dienstag has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Eugene R. Schiff, Jay H. Hoofnagle, Girish N. Vyas, Karen L. Lindsay, William M. Lee, John G. McHutchison, Herbert L. Bonkovsky, Anna S. Lok, Robert P. Perrillo and Timothy R. Morgan. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.